U.S. Will Buy 3.2 Million Doses of Novavax’s Covid Vaccine - The New York Times

The vaccine has not yet been authorized but is expected to be soon.

But a series of delays, largely the product of Novavaxs struggles with manufacturing, meant that the vaccine was not available last year, when the United States needed large quantities of vaccine dos… [+1003 chars]

full article...